Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer
Asia-Pacific Journal of Oncology Nursing · 2024-07 · 11 (7) · 100516
DOI: 10.1016/j.apjon.2024.100516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2024-07. Verfasst von Wenfang Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study adopts an evidence-based methodology to establish a comprehensive theory foundation for preoperative prehabilitation management in non-small cell lung cancer (NSCLC) patients.
Methods
A systematic literature review linked to prehabilitation management for NSCLC patients was conducted, utilizing reputable databases such as UpToDate, BMJ Best Practice, UK NICE, SIGN, GIN, Joanna Briggs Institute Library, Cochrane Library, Web of Science, Embase, OVID evidence-based database, PubMed, Chinese Wanfang database, CNKI, CBM, ATS, BTS, AACVPR, and EACTS. The search encompassed articles, including clinical decision-making, guidelines, evidence summaries, expert consensuses, and systematic reviews, from the inception of databases up to March 31st, 2023. Two researchers performed quality assessment of the literature and subsequent evidence extraction.
Results
Nineteen articles were included, comprising five guidelines, three expert consensuses, seven systematic reviews, and four randomized controlled trials. A total of 41 pieces of evidence were summarized, addressing key aspects such as the multidisciplinary team, appropriate patient population, prehabilitation modes, timing of prehabilitation, prehabilitation assessment, prehabilitation content, quality control, and effectiveness evaluation.
Conclusions
The synthesis of the best evidence for prehabilitation management in NSCLC patients provides a solid evidence-based foundation for its implementation. It is recommended that healthcare professionals conduct thorough patient evaluations, optimize and integrate medical resources, and collaboratively engage in interdisciplinarity efforts to develop and implement personalized and multimodal prehabilitation plans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Zitieren
APA
Wu, W., Li, H., & Fan, R. (2024). Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer. Asia-Pacific Journal of Oncology Nursing, 11(7), 100516. https://doi.org/10.1016/j.apjon.2024.100516
Vancouver
Wu W, Li H, Fan R. Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer. Asia-Pacific Journal of Oncology Nursing. 2024;11(7):100516. doi:10.1016/j.apjon.2024.100516
BibTeX
@article{Wu2024,
author = {Wu, Wenfang and Li, Huayan and Fan, Rongrong},
title = {Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2024},
volume = {11},
number = {7},
pages = {100516},
doi = {10.1016/j.apjon.2024.100516}
}
EUVIMED